Related references
Note: Only part of the references are listed.Fingolimod (FTY720) therapy in Japanese patients with relapsing multiple sclerosis over 12 months: results of a phase 2 observational extension
Jun-ichi Kira et al.
BMC NEUROLOGY (2014)
Changes in Th17 and regulatory T cells after fingolimod initiation to treat multiple sclerosis
Douglas Kazutoshi Sato et al.
JOURNAL OF NEUROIMMUNOLOGY (2014)
Distinct genetic and infectious profiles in Japanese neuromyelitis optica patients according to anti-aquaporin 4 antibody status
Satoshi Yoshimura et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
Characteristic Cerebrospinal Fluid Cytokine/Chemokine Profiles in Neuromyelitis Optica, Relapsing Remitting or Primary Progressive Multiple Sclerosis
Takuya Matsushita et al.
PLOS ONE (2013)
Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder
Ju-Hong Min et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
A randomized, controlled trial of fingolimod (FTY720) in Japanese patients with multiple sclerosis
T. Saida et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Emerging tumefactive multiple sclerosis after switching therapy from natalizumab to fingolimod
Sebastian Jander et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
TUMEFACTIVE MULTIPLE SCLEROSIS LESIONS UNDER FINGOLIMOD TREATMENT
Femke Visser et al.
NEUROLOGY (2012)
Fingolimod (FTY720), sphingosine 1-phosphate receptor modulator, shows superior efficacy as compared with interferon-β in mouse experimental autoimmune encephalomyelitis
Kenji Chiba et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2011)
The neurobiology of sphingosine 1-phosphate signaling and sphingosine 1-phosphate receptor modulators
Betty Soliven et al.
NEUROLOGY (2011)
Mechanism of Action of Oral Fingolimod (FTY720) in Multiple Sclerosis
Jerold Chun et al.
CLINICAL NEUROPHARMACOLOGY (2010)
Regulation of human Th9 differentiation by type I interferons and IL-21
Michael T. Wong et al.
IMMUNOLOGY AND CELL BIOLOGY (2010)
Th17 central memory T cells are reduced by FTY720 in patients with multiple sclerosis
M. Mehling et al.
NEUROLOGY (2010)
T-Helper 17 Cells Expand in Multiple Sclerosis and Are Inhibited by Interferon-β
Luca Durelli et al.
ANNALS OF NEUROLOGY (2009)
IL-9 as a mediator of Th17-driven inflammatory disease
Elizabeth C. Nowak et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Th1, Th17, and Th9 Effector Cells Induce Experimental Autoimmune Encephalomyelitis with Different Pathological Phenotypes
Anneli Jaeger et al.
JOURNAL OF IMMUNOLOGY (2009)
Aquaporin-4 autoimmune syndrome and anti-aquaporin-4 antibody-negative opticospinal multiple sclerosis in Japanese
T. Matsushita et al.
MULTIPLE SCLEROSIS JOURNAL (2009)
Regulation of IL-17 in human CCR6+ effector memory T cells
Hong Liu et al.
JOURNAL OF IMMUNOLOGY (2008)
Distinct CSF cytokine/chemokine profiles in atopic myelitis and other causes of myelitis
M. Tanaka et al.
NEUROLOGY (2008)
FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosis
M. Mehling et al.
NEUROLOGY (2008)
Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese
Takeshi Matsuoka et al.
BRAIN (2007)
Multiple sclerosis: a complicated picture of autoimmunity
Henry F. McFarland et al.
NATURE IMMUNOLOGY (2007)
FTY720 versus MMF with cyclosporine in de novo renal transplantation:: A 1-year, randomized controlled trial in Europe and Australasia
M. Salvadori et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
Diagnostic criteria for multiple sclerosis: 2005 Revisions to the McDonald Criteria
CH Polman et al.
ANNALS OF NEUROLOGY (2005)
Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis
T Ishizu et al.
BRAIN (2005)
Time-dependent cytokine deviation toward the Th2 side in Japanese multiple sclerosis patients with interferon beta-1b
HF Ochi et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2004)
Central memory and effector memory T cell subsets: Function, generation, and maintenance
F Sallusto et al.
ANNUAL REVIEW OF IMMUNOLOGY (2004)
Effect of glatiramer acetate (Copaxone) on CD4(+)CD25(high3) T regulatory cells and their IL-10 production in multiple sclerosis
P Putheti et al.
JOURNAL OF NEUROIMMUNOLOGY (2003)
Tc1/Tc2 and Th1/Th2 balance in Asian and Western types of multiple sclerosis, HTLV-I-associated myelopathy/tropical spastic paraparesis and hyperIgEaemic myelitis
H Ochi et al.
JOURNAL OF NEUROIMMUNOLOGY (2001)
Share Paper
